Asembia's Specialty Pharmacy Summit

Inflation Reduction Act (IRA) Implementation: Inflation-based rebates, Medicare price negotiation, Part D benefit design, and other IRA policies will have a profound impact on healthcare stakeholders. Avalere can help evaluate these policies’ effects and develop strategies for product development and investment decisions, manufacturer contracting strategies, plan formulary and benefit design, and ensuring patient access to medications.

Part D Strategy and Bid Modeling: Part D benefit redesign will add pressure to plans and manufacturers while increasing affordability for beneficiaries. Manufacturers can expect Part D volume and revenue changes and should prepare for new plan approaches to formulary and benefit design. Avalere can be a thought partner to manufacturers developing their strategy for engaging Part D plans for 2025 using qualitative and quantitative approaches.

Health Equity’s Role in Access: Abundant evidence shows persistent inequities in diagnosis, treatment, and outcomes experienced by consistently marginalized groups. Avalere takes a data-driven approach to pinpoint key drivers of those inequities, such as treatment variations, differential access to services and treatments, or social determinant factors such as affordability, transportation, and caregiver support.